Literature DB >> 22453082

ATM-dependent phosphorylation of the checkpoint clamp regulates repair pathways and maintains genomic stability.

Min Hwa Shin1, Ming Yuan, Hao Zhang, Joseph B Margolick, Mihoko Kai.   

Abstract

Upon genotoxic stress and during normal S phase, ATM phosphorylates the checkpoint clamp protein Rad9 in a manner that depends on Ser272. Ser272 is the only known ATM-dependent phosphorylation site in human Rad9. However, Ser272 phosphorylation is not required for survival or checkpoint activation after DNA damage. The physiological function of Ser272 remains elusive. Here, we show that ATM-dependent Rad9(Ser272) phosphorylation requires the MRN complex and controls repair pathways. Furthermore, the mutant cells accumulate large numbers of chromosome breaks and induce gross chromosomal rearrangements. Our findings establish a new and unexpected role for ATM: it phosphorylates the checkpoint clamp in order to control repair pathways, thereby maintaining genomic integrity during unperturbed cell cycle and upon DNA damage.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22453082      PMCID: PMC3372382          DOI: 10.4161/cc.20161

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  51 in total

1.  SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint.

Authors:  Parvin T Yazdi; Yi Wang; Song Zhao; Nimitt Patel; Eva Y-H P Lee; Jun Qin
Journal:  Genes Dev       Date:  2002-03-01       Impact factor: 11.361

2.  Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage.

Authors:  Seong-Tae Kim; Bo Xu; Michael B Kastan
Journal:  Genes Dev       Date:  2002-03-01       Impact factor: 11.361

Review 3.  Cell cycle checkpoint signaling through the ATM and ATR kinases.

Authors:  R T Abraham
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

4.  ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1.

Authors:  H Zhao; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

5.  Phosphorylation of human Rad9 is required for genotoxin-activated checkpoint signaling.

Authors:  Pia Roos-Mattjus; Kevin M Hopkins; Andrea J Oestreich; Benjamin T Vroman; Kenneth L Johnson; Stephen Naylor; Howard B Lieberman; Larry M Karnitz
Journal:  J Biol Chem       Date:  2003-04-21       Impact factor: 5.157

6.  A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome.

Authors:  Mark O'Driscoll; Victor L Ruiz-Perez; C Geoffrey Woods; Penny A Jeggo; Judith A Goodship
Journal:  Nat Genet       Date:  2003-03-17       Impact factor: 38.330

7.  Neocarzinostatin induces Mre11 phosphorylation and focus formation through an ATM- and NBS1-dependent mechanism.

Authors:  Shyng Shiou F Yuan; Hsueh Ling Chang; Ming Feng Hou; Te Fu Chan; Ying Hsien Kao; Yang Chang Wu; Jinu Huang Su
Journal:  Toxicology       Date:  2002-08-15       Impact factor: 4.221

8.  DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation.

Authors:  Christopher J Bakkenist; Michael B Kastan
Journal:  Nature       Date:  2003-01-30       Impact factor: 49.962

9.  Requirement of the MRN complex for ATM activation by DNA damage.

Authors:  Tamar Uziel; Yaniv Lerenthal; Lilach Moyal; Yair Andegeko; Leonid Mittelman; Yosef Shiloh
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

10.  DDK phosphorylates checkpoint clamp component Rad9 and promotes its release from damaged chromatin.

Authors:  Kanji Furuya; Izumi Miyabe; Yasuhiro Tsutsui; Francesca Paderi; Naoko Kakusho; Hisao Masai; Hironori Niki; Antony M Carr
Journal:  Mol Cell       Date:  2010-11-24       Impact factor: 17.970

View more
  9 in total

Review 1.  p53 and RAD9, the DNA Damage Response, and Regulation of Transcription Networks.

Authors:  Howard B Lieberman; Sunil K Panigrahi; Kevin M Hopkins; Li Wang; Constantinos G Broustas
Journal:  Radiat Res       Date:  2017-01-31       Impact factor: 2.841

Review 2.  DNA damage sensing by the ATM and ATR kinases.

Authors:  Alexandre Maréchal; Lee Zou
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

3.  The checkpoint clamp protein Rad9 facilitates DNA-end resection and prevents alternative non-homologous end joining.

Authors:  Feng-Ling Tsai; Mihoko Kai
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 4.  The ATM protein kinase: regulating the cellular response to genotoxic stress, and more.

Authors:  Yosef Shiloh; Yael Ziv
Journal:  Nat Rev Mol Cell Biol       Date:  2013-03-13       Impact factor: 94.444

5.  Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies.

Authors:  Lucía López-Corral; Luis Antonio Corchete; María Eugenia Sarasquete; María Victoria Mateos; Ramón García-Sanz; Encarna Fermiñán; Juan-José Lahuerta; Joan Bladé; Albert Oriol; Ana Isabel Teruel; María Luz Martino; José Hernández; Jesús María Hernández-Rivas; Francisco Javier Burguillo; Jesús F San Miguel; Norma C Gutiérrez
Journal:  Haematologica       Date:  2014-05-09       Impact factor: 9.941

6.  Phenothiazine Inhibitors of TLKs Affect Double-Strand Break Repair and DNA Damage Response Recovery and Potentiate Tumor Killing with Radiomimetic Therapy.

Authors:  Sharon Ronald; Sanket Awate; Abhijit Rath; Jennifer Carroll; Floyd Galiano; Donard Dwyer; Heather Kleiner-Hancock; J Michael Mathis; Simone Vigod; Arrigo De Benedetti
Journal:  Genes Cancer       Date:  2013-01

7.  ALDH1A1 Deficiency in Gorlin Syndrome Suggests a Central Role for Retinoic Acid and ATM Deficits in Radiation Carcinogenesis.

Authors:  Thomas J Weber; Thierry Magnaldo; Yijia Xiong
Journal:  Proteomes       Date:  2014-09-11

8.  Role of the checkpoint clamp in DNA damage response.

Authors:  Mihoko Kai
Journal:  Biomolecules       Date:  2013-01-16

9.  RNA binding protein RBM14 promotes radio-resistance in glioblastoma by regulating DNA repair and cell differentiation.

Authors:  Ming Yuan; Charles G Eberhart; Mihoko Kai
Journal:  Oncotarget       Date:  2014-05-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.